In 2005, when the Labour Party decided to implement the National Identity Project (NIP) in the UK, it drew severe criticism from many quarters, including the Tories, who later scrapped the NIP after coming to power. A report by the London School of Economics (LSE), which stated the project is “unsafe in law” and should be regarded as a “potential danger to public interest”, was instrumental in buttressing the arguments...
More »SEARCH RESULT
Total Matching Records found : 593
The trouble with junk food-Sunita Narain
-The Business Standard It is not in the interest of food companies to advertise what their products contain, but it is in our interest to know Junk food is junk by its very definition. But how bad is it and what is it that companies do not tell people about this food? This is what the Centre for Science and Environment (CSE) laboratory checked. The results were both predictable and alarming....
More »NREGA: Wages are often denied or delayed, with corruption rife-Inayat Sabhikhi
-The Economic Times Shibu Joseph ( Why I am Quitting my Job, ET, March 29) suggests, tongue-in-cheek, that he should quit the drudgery of corporate life and, instead, enjoy the "freebies" given to the aam aadmi, like the right to work under the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA). I am not going to write on behalf of the crores of people who work in this programme, because I am...
More »Question of efficacy -Leena Menghaney
The country is clearly shaping its legislation to promote access to medicines by fostering generic production. INDIA'S approach to the revision of its Patents Act in 2005 is a clear example of a country shaping its legislation to promote access to medicines by fostering generic production. Although World Trade Organisation (WTO) rules made it mandatory for India to put in place a patent regime for medicines by 2005, nothing obliges...
More »Patent to plunder -Amit Sengupta
India's efforts to produce and supply life-saving drugs at affordable prices face challenges from multinational companies trying to “evergreen” their patents. THE average life expectancy across the globe has increased from around 30 years a century ago to over 65 years today. This has been made possible in large part by modern medicine. Never before in history have humans had access to such an array of medicines and devices to...
More »
